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Abstract Oxygen-derived free radicals have been implicated in
the pathogenesis of acute pancreatitis, yet adaptive responses in
the pancreas in vivo to oxidative stress remain poorly defined.
We have investigated expression of the stress protein heme
oxygenase in the intact pancreas of rats with caerulein-induced
pancreatitis and in cultured pancreatic acinar and islet cell lines.
Expression of inducible heme oxygenase-1 (HO-1) in the
pancreas in vivo was enhanced 12^24 h after induction of





, methyl viologen, cadmium chloride and
diethylmaleate enhanced HO-1 expression in a dose- and time-
dependent manner, without altering expression of constitutive
HO-2. Enhanced expression of HO-1 in the pancreas in vivo and
pancreatic islet and acinar cells may contribute to cellular
defences against oxidative stress associated with acute pancrea-
titis.
z 1997 Federation of European Biochemical Societies.
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1. Introduction
Microsomal heme oxygenase (HO) has been identi¢ed as a
stress protein induced in many cell types by various stimulants
such as oxidative stress and sulfhydryl-reactive agents [1]. HO
is the most e¤cient heme degrading system and produces al-
most exclusively biliverdin and carbon monoxide (CO) as
heme degradation products [1,2]. The cytosolic enzyme bili-
verdin reductase subsequently catalyzes the two-electron re-
duction of biliverdin to bilirubin, a powerful chain-breaking
antioxidant [3^5]. Two isoforms of HO have been identi¢ed,
an inducible form HO-1 (V32 kDa) and a constitutive form
HO-2 (V34 kDa). Accumulating evidence suggests that heme
oxygenase plays an important role in regulating vascular tone
through carbon monoxide mediated increases in intracellular
cGMP levels in smooth muscle cells [6,7] and neuronal trans-
mission [8]. Constitutive HO-2 has recently been identi¢ed
immunocytochemically in endothelial cells, adventitial nerves
of blood vessels and ganglia of the myenteric plexus in the
intestine [9], suggesting that HO and nitric oxide synthase may
act in concert to modulate vascular tone and the autonomic
nervous system.
Pancreatitis is a disease of increasing incidence and covers a
spectrum of pathophysiological alterations in the pancreas
and other organs [10,11]. Oxidative stress has been implicated
in the pathophysiology of pancreatitis [12], yet the cellular
mechanisms underlying secretory dysfunction remain to be
elucidated. Glutathione (GSH) metabolism and lipid peroxi-
dation have been measured as indicators of free radical medi-
ated damage in acute pancreatitis, and there is general agree-
ment that GSH and other sulfhydryl compounds are depleted
while lipid peroxidation is increased in pancreatic tissue (see
reviews [13,14]). Moreover, other indices, such as acinar cell
injury and oedema show a marked improvement following
treatment with enzymic antioxidants, vitamin C analogues,
GSH monoethyl ester and GSH prodrugs [14]. Thus, endog-
enous antioxidant defence mechanisms in both pancreatic aci-
nar and islet cells may be critically important in preventing
the onset or diminishing the severity of acute pancreatitis.
In the present study we have used the caerulein-induced
model of acute pancreatitis to investigate expression of HO
during the progression of pancreatitis in the rat in vivo. To
resolve whether pancreatic endocrine and exocrine cells exhib-
it a di¡erential sensitivity to oxidative stress, we also inves-




and methyl viologen and sulfhyd-
ryl-reactive agents diethylmaleate and cadmium chloride on
HO expression in pancreatic islet (LTC3, [15]) and acinar
(AR42J, [16]) cell lines.
2. Materials and methods
2.1. Materials
Dulbecco's modi¢ed Eagle's medium (DMEM), cadmium chloride,
diethylmaleate and hydrogen peroxide were purchased from Sigma
Chemical Co., Poole, UK. Horseradish peroxidase conjugated goat
anti-rabbit immunoglobulin and BCA protein assay reagents were
purchased from Pierce, Chester, UK. Polyvinylidene di£uoride mem-
brane (Immobilon-P) was purchased from Millipore, Watford, UK.
Enhanced chemiluminescence Western blotting detection reagents and
Hyper¢lm-MP autoradiography ¢lm were purchased from Amersham
International, Amersham, UK.
2.2. Induction of caerulein pancreatitis in rats in vivo
Male Sprague-Dawley rats were kept on a 12-h light-dark cycle
with free access to water and a standard laboratory diet (No. 491,
Grain Harvesters Ltd., Kent, UK). As described previously [17], rats
weighing 190^250 g received four intraperitoneal injections of either
saline (0.9%) or 20 Wg/kg body weight of caerulein (a pancreatic sec-
retagogue) at hourly intervals. Animals were killed by cervical dislo-
cation 1, 12, 24 h after the last intraperitoneal injection of caerulein or
saline, and pancreatic, heart and liver tissues were the removed sur-
gically. Tissue specimens were rinsed with ice-cold phosphate-bu¡ered
saline containing 0.1 mM phenylmethylsulfonyl £uoride and homo-
genized in SDS sample bu¡er (2% SDS, 10% glycerol, 50 mM Tris-
HCl (pH 6.8) and 0.1 mM phenylmethylsulfonyl £uoride).
2.3. Culture of pancreatic LTC3 islet and AR42J acinar cell lines
The pancreatic islet LTC3 cell line (see [15]) was kindly provided by
Dr. Elaine Baileys from Addenbrooks Hospital, University of Cam-
FEBS 18336 24-10-97
0014-5793/97/$17.00 ß 1997 Federation of European Biochemical Societies. All rights reserved.
PII S 0 0 1 4 - 5 7 9 3 ( 9 7 ) 0 0 1 9 1 - 9
*Corresponding author. Fax: (44) (171) 333 4008.
E-mail: g.mann@kcl.ac.uk
FEBS 18336 FEBS Letters 405 (1997) 219^223
bridge. The pancreatic AR42J acinar cell line (see [16]) was obtained
from the American Type Culture Collection, Rockville, MD, USA.
Both cell lines were cultured routinely in DMEM supplemented with
10% fetal calf serum, 2 mM L-glutamine, 50 U/ml penicillin, 50 Wg/ml
streptomycin in an incubator at 37³C in a 5% CO
2
atmosphere. Cells
were subcultured every 4 or 5 days with a split ratio of 1:2 or 1:3 for
LTC3 cells, or every 2 or 3 days with a split ratio from 1:5 to 1:10 for
AR42J cells.
LTC3 and AR42J cells were seeded into 24-well microtitre plates at




cells/ml, respectively. Cells were cul-
tured for 24 h and then incubated for speci¢ed time intervals with or
without stress agents. The medium was then removed, and the cells
were rinsed three times with Dulbecco's phosphate-bu¡ered saline and
lysed with 0.1 ml of SDS sample bu¡er.
2.4. Determination of heme oxygenase protein expression
Sample total protein content was determined using the BCA protein
assay reagents and 3% 2-mercaptoethanol was added. An equal pro-
tein concentration from each sample was then boiled for 3 min and
separated by 13% SDS-polyacrylamide gel electrophoresis. Separated
proteins were transferred to a polyvinylidene di£uoride membrane
and probed with polyclonal rabbit anti-rat HO-1 and HO-2 antibodies
[18,19]. A horseradish peroxidase conjugated goat anti-rabbit secon-
dary antibody was used in conjugation with enhanced chemilumines-
cence to visualise the HO bands on autoradiography ¢lm.
3. Results
3.1. Expression of HO-1 in pancreatic tissue in caerulein-
induced pancreatitis
Caerulein, a decapeptide cholecystokinin analogue, causes
acute pancreatitis in rats when administered in supraphysio-
logical doses [20]. To investigate the e¡ects of acute pancrea-
titis on expression of HO in vivo, pancreatitis was induced in
rats by administering caerulein intraperitoneally (see Section
2). Protein extracts of pancreatic, heart and liver were then
analyzed by Western blotting (Fig. 1A). HO-1 expression was
not detected in the pancreas 1 h after treatment of rats with
either caerulein or 0.9% NaCl, although interstitial oedema
was observed in caerulein-treated animals. HO-1 was ex-
pressed selectively in pancreatic tissue 12^24 h after treatment
of rats with caerulein, whereas expression of HO-1 in the liver
remained unchanged and HO-1 was hardly detected in the
heart. Constitutively expressed HO-2 was barely detectable
in the pancreas or heart of rats treated with caerulein or
NaCl. Although HO-2 was clearly expressed in the liver of
rats treated with either NaCl or caerulein (Fig. 1B), we were
unable to detect changes in HO-2 expression in the liver,
pancreas or heart over the 1^24 experimental period (data
not shown).
3.2. Expression of HO-1 in pancreatic islet LTC3 and acinar
AR42J cell lines
Basal expression of HO-1 was low in untreated pancreatic
LTC3 islet cells (Fig. 2). Cadmium chloride and diethylma-
leate enhanced HO-1 expression in a dose- and time-depend-





gen, which generates O
3
2
in cells [21], also enhanced HO-1
expression. With the exception of methyl viologen, maximal
expression of HO-1 was observed after 12^24 h exposure to
the stress agents. Methyl viologen induced maximal HO-1
expression only after 48 h.
Basal expression of HO-1 was also very low in untreated
pancreatic AR42J acinar cells (Fig. 3), and as in LTC3 islet





viologen increased HO-1 expression in a dose-dependent man-
ner (Fig. 3A). When the time-dependent e¡ects of cadmium
chloride and the electrophilic agent diethylmaleate were exam-
ined, both agents increased HO-1 expression maximally over
6^12 h (Fig. 3B), and levels of protein expression then de-
creased by 48 h. A similar pattern of HO-1 expression was





yl viologen for up to 48 h (data not shown).
Constitutive HO-2 was detected under basal conditions in
pancreatic LTC3 islet cells, and expression of HO-2 was un-
a¡ected by oxidative stress and sulfhydryl-reactive agents
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Fig. 1. Expression of heme oxygenase in the pancreas, heart and liver in vivo. Pancreatic, heart and liver tissues were removed at 1, 12, 24 h
after the last of four intraperitoneal injections of either 0.9% saline (N) or caerulein (CL, 20 Wg/kg body weight). Expression of HO-1 (A) and
HO-2 (B) was determined by Western blot analysis. Data are representative of measurements in 3 animals.
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(data not shown). By comparison, expression of HO-2 in pan-
creatic AR42J acinar cells was very low and not enhanced by





e¡ect on the expression of either HO-1 or HO-2 in AR42J
acinar cells when added directly to the culture medium (24 h,
data not shown). Treatment of either LTC3 or AR42J cells
with oxidative stress or sulfhydryl-reactive agents at concen-
trations and time periods used in this study did not a¡ect cell
viability, as determined by the exclusion of trypan blue dye.
4. Discussion
Evidence for the involvement of oxygen-derived free radi-
cals in the pathogenesis of pancreatitis is increasing (see [12^
14]), yet the molecular events mediating secretory dysfunction
in both the exocrine and endocrine pancreas remain to be
investigated. Although some studies have shown that heat
shock proteins (HSP70, HSP90) and HO-1 are expressed in
pancreatic cells in response to pro-in£ammatory cytokines
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Fig. 3. Dose- and time-dependent enhancement of HO-1 expression in pancreatic AR42J acinar cells. (A) Cells were incubated in the presence






or methyl viologen for 12 h. (B) Cells were incubated for 6^48 h in the absence
(control) or presence of 10 WM CdCl
2
and 100 WM DEM. Equal amounts of proteins were electrophoresed and analyzed by Western blotting.
Data are representative of experiments in 3 di¡erent cell cultures.
Fig. 2. Dose- and time-dependent enhancement of HO-1 expression in pancreatic LTC3 islet cells. (A) Cells were incubated in the presence of
increasing concentrations of either cadmium chloride (CdCl
2




for 12 h, or with methyl viologen (MV) for 48
h. (B) Cells were incubated for 6^48 h in the absence (control) or presence of 10 WM CdCl
2




or 100 WM methyl
viologen. Equal amounts of proteins were electrophoresed and analyzed by Western blotting. Data are representative of experiments in 3^4 dif-
ferent cell cultures.
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[22^24], there is no consensus as to whether these proteins are
involved in the protection against oxygen radical cytotoxicity.
We have established that caerulein-induced acute pancrea-
titis in rats in vivo is associated with a signi¢cant increase in
the expression of HO-1 in pancreatic tissue, occurring 12^24 h
after the ¢rst signs of interstitial oedema in the pancreas.
Although we cannot exclude the possibility that in¢ltrating
phagocytes in pancreatic tissue may have contributed to the
enhanced expression of HO-1, it seems more likely that en-
hanced expression of HO-1 in vivo is attributable to pancre-
atic cells. The time course of this selective induction of HO-1
in the pancreas in vivo may re£ect an adaptive response to the
generation of reactive oxygen radicals in the early stages of
acute pancreatitis [13,14]. Interestingly, induction of the heat
shock protein HSP60 in the rat pancreas in response to stress
induced by water immersion has been reported to prevent the
pancreatic interstitial oedema and serum amylasaemia associ-
ated with pancreatitis induced subsequently with caerulein
[25]. As constitutive HO-2 was hardly detectable in the pan-
creas in vivo in the present study, enhanced expression of HO-
1 and heat shock proteins may constitute a key cellular de-
fence against both oxidative and environmental stress.
Adaptive responses in HO-1 expression were also detected
in pancreatic islet (LTC3) and acinar (AR42J) cell lines ex-
posed to oxidative or sulfhydryl stress agents, with LTC3 cells
exhibiting a greater sensitivity to oxidative stress. The en-





con¢rms a previous report in rat islets [23]. As islet
cells express only low levels of MnSOD and glutathione per-
oxidase [26], synthesis of HO-1 and heat shock proteins may
o¡er an alternative defence against oxidative stress in L-cells.
Unlike HO-1, only very low levels of HO-2 expression were
detected in cultured pancreatic islet and acinar cells.
The mechanisms by which oxidative stress and sulfhydryl-
reactive agents enhance expression of HO-1 still remain un-
clear. One possibility is that alterations in the levels of the key
intracellular antioxidant glutathione (GSH) may in£uence
HO-1 expression. The stress agents employed in the present
study are known to decrease GSH levels and/or form GSH
conjugates. In Chinese hamster ovary cells, a decrease in in-
tracellular GSH induces expression of HO-1 [27], while low-
ering GSH levels in murine peritoneal macrophages is not
su¤cient for HO-1 induction [28]. In animals treated with
high doses of caerulein, the total pancreatic glutathione con-
tent falls during the early stages acute oedematous pancreatitis
[14,29]. Thus, it seems reasonable to conclude that the de-
crease in intracellular GSH caused by reactive oxygen radicals
represents one pathway for enhanced expression of HO-1 in
acute caerulein-induced pancreatitis. However, addition of
caerulein directly to the culture medium in our experiments
had no e¡ect on HO-1 expression in AR42J acinar cells (data
not shown). Caerulein is known to bind to cholecystokinin
receptors (CCKA) in AR42J acinar cells [30]. The lack of
an e¡ect of caerulein on HO-1 expression in AR42J cells in
vitro may re£ect a di¡erential sensitivity to caerulein in the
cultured cell line.
Carbon monoxide (CO) generated from heme metabolism
by HO elevates cGMP levels in smooth muscle cells [6,7] and
has been implicated as a regulator of cGMP production in the
brain, where expression of HO-1 compensates for a depression
in nitric oxide (NO) synthase activity [31]. Generation of NO
mediates carbachol-stimulated increases in cGMP and calcium
in£ux in pancreatic acinar cells, events involved in exocrine
pancreatic secretion [32,33]. Furthermore, Seo et al. [34] have
recently shown that treatment of rat pancreatic tissue with







levels and amylase release. These ¢ndings are, however, at
variance with the study by Gilon et al. [35], who concluded
that the increase in intracellular cGMP level depends on,
rather than mediates, increases in intracellular calcium.
The present study has shown that only very low basal levels
of heme oxygenase are expressed in the pancreas in vivo and
acinar cells in vitro. It thus seems likely that in oxidative stress
associated with acute pancreatitis enhanced expression of HO-
1 would lead to an increased generation of CO which in con-
cert with NO may contribute to the regulation of cGMP levels
in acinar cells and exocrine pancreatic secretion. As regards
the antioxidant potential of HO-1, recent evidence clearly
demonstrates that overexpression of heme oxygenase moder-
ates cell damage induced in rabbit coronary microvessel en-
dothelial cells by recombinant haemoglobin and heme [36]
and enhances the resistance of human pulmonary epithelial
cells to non-heme mediated oxidant injury [37]. Thus, in-
creased expression of HO-1 detected in pancreatic endocrine
and exocrine cells may serve as a key defence mechanism
against oxidative stress associated with acute in£ammatory
pancreatitis.
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